Breast cancer remains the second most common cancer among women, accounting for 30% of all new female cancers annually in the United States.1 Breast-conserving surgery (BCS), or lumpectomy, is a commonly used surgical technique, but positive margins can necessitate additional surgical intervention, such as a re-excision or conversion to mastectomy.
Discover the latest insights from a peer-reviewed study conducted by physicians at MD Anderson and UT Health Houston. This webinar dives into the critical issue of reoperations in BCS, exploring the associated costs, complications, and profound impact on patients and healthcare systems.
Dr. Nina Tamirisa is a Breast Surgical Oncologist and Assistant Professor at the University of Texas MD Anderson Cancer Center in Houston, Texas. During her time in general surgery residency, she obtained a Masters in Clinical Science to pursue health services research and then completed a fellowship in breast surgical oncology at Duke University. Dr. Tamirisa has an interest in healthcare innovation and aging research in the delivery of breast cancer care.
Dr. Ted James is the Chief of Breast Surgical Oncology and Co-Director of the Breast Care Center at Beth Israel Deaconess Medical Center. He is also an Associate Professor of Surgery at Harvard Medical School. Dr. James is an advocate of patient-centered care and believes that treatment should always incorporate the individual priorities and values of each patient. He works with national health organizations to improve outcomes and ensure that patients receive the best care possible.
This webinar is supported by Perimeter Medical Imaging through a marketing grant. It is not part of the official American Society of Breast Surgeons educational programming and no AMA PRA Category 1 Credits™ have been assigned to them by the ASBrS.
1. American Cancer Society web page: https://www.cancer.org/cancer/types/breast-cancer/about/how-common-is-breast-cancer.html